Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on FRX
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Forest Laboratories, Inc. (NY:FRX)
Delayed:
37.51
-0.41 (1.08%)
Trade Now!
Previous Close
$37.92
52 Week High
$39.09
Open
$37.88
52 Week Low
$31.28
Day High
$38.12
P/E
N/A
Day Low
$37.44
EPS
$-0.12
Volume
1,813,292
Friends, Peers and Foes
(?)
:
IRWD
,
AZN
,
ALM
,
VHS
,
WAG
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 17, 2013 05:26 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Meury William
May 17, 2013 05:26 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Taglietti Marco
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Walsh Kevin
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Zimmerman Joseph
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Lynch Jerome
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Weinstein Herschel S
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: SOLOMON HOWARD
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Francis Perier I Jr
May 17, 2013 05:23 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Murdolo Frank J
May 17, 2013 05:23 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: HOCHBERG ELAINE
View All Articles
Apr 23, 2013 07:05 AM
Forest Laboratories, Inc. (FRX) Tops Q4 EPS by 1c, Sales Miss Views
Jan 15, 2013 07:05 AM
Forest Laboratories, Inc. (FRX) Misses Q3 EPS by 7c; Eases FY13 Outlook
Oct 16, 2012 08:00 AM
Forest Laboratories, Inc. (FRX) Posts Q2 EPS of 50c; Revs Heavy
Jul 17, 2012 08:01 AM
Forest Laboratories, Inc. (FRX) Tops Q1 EPS by 4c
Jun 11, 2012 08:04 AM
Forest Labs (FRX) Cuts FY13 Outlook Amid 'Evolving Conditions in the Lexapro/escitalopram Market
Apr 17, 2012 08:01 AM
Forest Laboratories, Inc. (FRX) Tops Q4 EPS by 8c; Guides FY13 Above
Jan 17, 2012 08:03 AM
Forest Laboratories, Inc. (FRX) Tops Q3 EPS by 3c; Raises FY12 Outlook
Oct 18, 2011 08:00 AM
Forest Laboratories, Inc. (FRX) Reports Q2 Miss; Reaffirms FY12 Outlook
Jul 19, 2011 08:01 AM
Forest Laboratories, Inc. (FRX) Tops Q1 EPS by 7c
View All Major News
May 15, 2013 05:44 PM
Carl Icahn's Q1 13F Reveals Little New
May 9, 2013 05:42 PM
BMO Capital Starts Forest Laboratories (FRX) at Underperform
May 1, 2013 02:18 PM
Forest Labs (FRX), Almirall Report Positive Results from 2nd AUGMENT COPD Phase III
Apr 23, 2013 07:05 AM
Forest Laboratories, Inc. (FRX) Tops Q4 EPS by 1c, Sales Miss Views
Apr 22, 2013 03:31 PM
Forest Laboratories (FRX) 'Day of Reckoning' Not Far Off
Apr 22, 2013 03:09 PM
Trading Radar for 04/23: Apple (AAPL), AT&T (T), United Tech (UTX), Yum! (YUM), VMware (VMW) Report
Feb 12, 2013 12:38 PM
AstraZeneca's (AZN) Best Chance to Regain Profitability? One Major Acquisition...
Jan 31, 2013 10:40 AM
Notable Analyst Rating Changes 01/31: (FB) (VALE) (AJG) Upgraded; (RF) (PCLN) (VELT) Downgraded
Jan 31, 2013 09:19 AM
Janney Montgomery Scott Starts Forest Laboratories (FRX) at Buy
Jan 15, 2013 07:07 AM
Ironwood (IRWD) Updates on Q4 Sales; LINZESS Breaks $19M Mark
View All Reports
May 17, 2013 08:08 AM
Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference
May 16, 2013 08:00 AM
Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting
May 14, 2013 08:00 AM
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013
May 9, 2013 06:00 AM
Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure
May 9, 2013 06:00 AM
Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure
May 1, 2013 02:17 PM
Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol combination in COPD
Apr 23, 2013 07:00 AM
Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Acquisition Amortization
Apr 16, 2013 02:30 AM
Almirall and Forest Laboratories Announce Positive Phase III Study Results for Aclidinium and Formoterol Combination in COPD
Apr 2, 2013 10:07 AM
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Fourth Quarter Earnings
View All Press Releases
May 17, 2013 05:26 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Meury William
May 17, 2013 05:26 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Taglietti Marco
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Walsh Kevin
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Zimmerman Joseph
May 17, 2013 05:25 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Lynch Jerome
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Weinstein Herschel S
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: SOLOMON HOWARD
May 17, 2013 05:24 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Francis Perier I Jr
May 17, 2013 05:23 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: Murdolo Frank J
May 17, 2013 05:23 PM
Form 4 FOREST LABORATORIES INC For: May 15 Filed by: HOCHBERG ELAINE
View All Filings
Entities mentioned with
FRX
Carl Icahn
|
View Related Stories »
Earnings
|
View Related Stories »
Needham & Company
|
View Related Stories »
Citi
|
View Related Stories »
UBS
|
View Related Stories »
JPMorgan
|
View Related Stories »
Bank of America
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Trading Radar
|
View Related Stories »
Forest Laboratories/Clinical Data
|
View Related Stories »
Barclays
|
View Related Stories »
Dividend
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
13D
|
View Related Stories »
Soleil Securities
|
View Related Stories »
Goldman Sachs
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Argus
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Collins Stewart
|
View Related Stories »
Show More...
View All Entities